Hypogonadism as a risk factor for cardiovascular mortality in men: A meta-analytic study

European Journal of Endocrinology

Volumn 165, Issue 5, 2011, Pages 687-701

  Corona, Giovanni ^a,b   Rastrelli, Giulia ^a   Monami, Matteo ^a   Guay, André ^c   Buvat, Jaques ^d   Sforza, Alessandra ^b   Forti, Gianni ^a   Mannucci, Edoardo ^a   Maggi, Mario ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Azienda USL di Bologna   (Italy)

^c LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^d Centre d'Etude et de Traitement de la Pathologie de l'Appareil Reproducteur et de la Psychosomatique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; PLACEBO; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

ANDROGEN THERAPY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; HUMAN; HYPOGONADISM; LONGITUDINAL STUDY; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; ST SEGMENT DEPRESSION; SYSTEMATIC REVIEW; TREADMILL EXERCISE;

ANIMALS; CARDIOVASCULAR DISEASES; ESTRADIOL; HUMANS; HYPOGONADISM; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TESTOSTERONE;

EID: 80054797449     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0447     Document Type: Review

References (136)

1. Corona G, Rastrelli G, Vignozzi L, Mannucci E & Maggi M. Testosterone, cardiovascular disease and the metabolic syndrome. Best Practice & Research. Clinical Endocrinology & Metabolism 2011 25 337-353. (doi:10.1016/j.beem.2010.07. 002)
2. Atlas of health in Europe, 2nd edition 2008. WHO Library Cataloguing-in-Publication 2008.
3. Courtenay WH & Keeling RP. Men, gender, and health: toward an interdisciplinary approach. Journal of American College Health 2000 48 243-246. (doi:10.1080/07448480009596265)
4. Stramba-Badiale M, Fox KM, Priori SG, Collins P, Daly C, Graham I, Jonsson B, Schenck-Gustafsson K & Tendera M. Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. European Heart Journal 2006 27 994-1005. (doi:10.1093/eurheartj/ ehi819)
5. Wingard DL, Suarez L & Barrett-Connor E. The sex differential in mortality from all causes and ischemic heart disease. American Journal of Epidemiology 1983 117 165-172. (Pubitemid 13194920)
6. Osler W. Lectures on Angina Pectoris and Allied States. New York, NY: D Appleton & Co, 1897.
7. Friedman M & Rosenman RH. Association of specific overt behavior pattern with blood and cardiovascular findings: blood cholesterol level, blood clotting time, incidence of arcus senilis, and clinical coronary artery disease. Journal of the American Medical Association 1959 169 1286-1296.
8. Haynes SG, Levine S, Scotch N, Feinleib M & Kannel WB. The relationship of psychosocial factors to coronary heart disease in the Framingham Study, 1: methods and risk factors. Journal of the American Medical Association 1978 107 362-383. (Pubitemid 9003484)
9. Bem SL. The measurement of psychological androgyny. Journal of Consulting and Clinical Psychology 1974 42 155-162. (doi:10. 1037/h0036215)
10. Tudiver F & Talbot Y. Why don't men seek help? Family physicians' perspectives on help-seeking behaviour in men Journal of Family Practice 1999 48 47-52. (Pubitemid 29069503)
11. Guay A, Seftel AD & Traish A. Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses. International Journal of Impotence Research 2010 22 9-19. (doi:10.1038/ijir.2009.46)
12. Buvat J, Maggi M, Gooren L, Guay AT, Kaufman J, Morgentaler A, Schulman C, Tan HM, Torres LO, Yassin A & Zitzmann M. Endocrine aspects of male sexual dysfunctions. Journal of Sexual Medicine 2010 7 1627-1656. (doi:10.1111/j.1743-6109.2010. 01780.x)
13. Ruige JB, Mahmoud AM, De Bacquer D & Kaufman JM. Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart 2010 97 870-875. (doi:10.1136/ hrt.2010.210757)
14. Poggi UL, Argüelles AE, Rosner J, de Laborde NP, Cassini JH & Volmer MC. Plasma testosterone and serum lipids in male survivors of myocardial infarction. Journal of Steroid Biochemistry 1976 7 229-231. (doi:10.1016/0022- 4731(76)90206-5)
15. Halim MM, Meyrick G, Jeans WD, Murphy D & Burton JL. Myocardial infarction, androgen and the skin. British Journal of Dermatology 1978 98 63-68. (doi:10.1111/j.1365-2133.1978. tb07334.x)
16. Entrican JH, Beach C, Carroll D, Klopper A, Mackie M & Douglas AS. Raised plasma oestradiol and oestrone levels in young survivors of myocardial infarction. Lancet 1978 2 487-490. (doi:10.1016/S0140-6736(78)92215-8)
17. Taggart H, Sheridan B & Stout RW. Sex hormone levels in younger male stroke survivors. Atherosclerosis 1980 35 123-125. (doi:10.1016/0021-9150(80) 90034-9)
18. Foresta C, Ruzza G, Mioni R, Dalla Costa F & Mastrogiacomo I. Male hypogonadism in aorto-iliac arteriopathies. Archives of Andrology 1982 9 297-301. (doi:10.3109/0148501820899 0254)
19. Klaiber EL, Broverman DM, Haffajee CI, Hochman JS, Sacks GM & Dalen JE. Serum estrogen levels in men with acute myocardial infarction. American Journal of Medicine 1982 73 872-881. (doi:10.1016/0002-9343(82)90779-3)
20. Luria MH, Johnson MW, Pego R, Seuc CA, Manubens SJ, Wieland MR &Wieland RG. Relationship between sex hormones, myocardial infarction, and occlusive coronary disease. Archives of Internal Medicine 1982 142 42-44. (doi:10.1001/archinte.142. 1.42)
21. Labropoulos B, Velonakis E, Oekonomakos P, Laskaris J & Katsimades D. Serum sex hormones in patients with coronary disease and their relationship to known factors causing atherosclerosis. Cardiology 1982 69 98-103. (doi:10.1159/ 000173490)
22. Zumoff B, Troxler RG, O'Connor J, Rosenfeld RS, Kream J, Levin J, Hickman JR, Sloan AM, Walker W, Cook RL & Fukushima DK. Abnormal hormone levels in men with coronary artery disease. Arteriosclerosis 1982 2 58-67. (doi:10.1161/01.ATV.2.1.58)
23. Barth JD, Jansen H, Hugenholtz PG & Birkenhäger JC. Post-heparin lipases, lipids and related hormones in men undergoing coronary arteriography to assess atherosclerosis. Atherosclerosis 1983 48 235-241. (doi:10.1016/0021- 9150(83)90041-2)
24. Phillips GB, Castelli WP, Abbott RD & McNamara PM. Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort. American Journal of Medicine 1983 74 863-869. (doi:10.1016/0002-9343(83) 91078-1)
25. Hromadová M, Hácik T & Riecanský I. Concentration of lipid, apoprotein-B and testosterone in patients with coronarographic findings. Klinische Wochenschrift 1985 63 1071-1074. (doi:10. 1007/BF01739675)
26. Aksüt SV, Aksüt G, Karamehmetoglu A & Oram E. The determination of serum estradiol, testosterone and progesterone in acute myocardial infarction. Japanese Heart Journal 1986 27 825-837. (doi:10.1536/ihj.27.825)
27. Franzén J & Fex G. Low serum apolipoprotein A-I in acute myocardial infarction survivors with normal HDL cholesterol. Atherosclerosis 1986 59 37-42. (doi:10.1016/0021-9150(86) 90030-4)
28. Sewdarsen M, Jialal I, Vythilingum S & Desai R. Sex hormone levels in young Indian patients with myocardial infarction. Arteriosclerosis 1986 6 418-421. (doi:10.1161/01.ATV.6.4. 418)
29. Chute CG, Baron JA, Plymate SR, Kiel DP, Pavia AT, Lozner EC, O'Keefe T & MacDonald GJ. Sex hormones and coronary artery disease. American Journal of Medicine 1987 83 853-859. (doi:10. 1016/0002-9343(87)90642-5)
30. Hämäläinen E, Tikkanen H, Härkönen M, Näveri H & Adlercreutz H. Serum lipoproteins, sex hormones and sex hormone binding globulin in middle-aged men of different physical fitness and risk of coronary heart disease. Atherosclerosis 1987 67 155-162. (doi:10.1016/0021-9150(87)90275-9)
31. Lichtenstein MJ, Yarnell JW, Elwood PC, Beswick AD, Sweetnam PM, Marks V, Teale D & Riad-Fahmy D. Sex hormones, insulin, lipids, and prevalent ischemic heart disease. American Journal of Epidemiology 1987 126 647-657. (Pubitemid 17142236)
32. Small M, MacRury S, Beastall GH & MacCuish AC. Oestradiol levels in diabetic men with and without a previous myocardial infarction. Quarterly Journal of Medicine 1987 64 617-623. (Pubitemid 17118720)
33. Barrett-Connor E & Khaw KT. Endogenous sex hormones and cardiovascular disease inmen.Aprospective population-based study. Circulation 1988 78 539-545. (doi:10.1161/01.CIR.78.3.539)
34. Phillips GB, Yano K & Stemmermann GN. Serum sex hormone levels and myocardial infarction in the Honolulu Heart Program. Pitfalls in prospective studies on sex hormones. Journal of Clinical Epidemiology 1988 41 1151-1156. (doi:10.1016/0895-4356 (88)90018-2)
35. Sewdarsen M, Jialal I & Naidu RK. The low plasma testosterone levels of young Indian infarct survivors are not due to a primary testicular defect. Postgraduate Medical Journal 1988 64 264-266. (doi:10.1136/pgmj.64.750.264)
36. Słowínska-Srzednicka J, Zgliczyński S, Ciświcka-Sznajderman M, Srzednicki M, Soszyński P, Biernacka M, Woroszyłska M, Ruzyłło W & Sadowski Z. Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction. Atherosclerosis 1989 79 197-203. (doi:10.1016/0021-9150(89)90124-X)
37. Elwan O, Abdallah M, Issa I, Taher Y & el-Tamawy M. Hormonal changes in cerebral infarction in the young and elderly. Journal of Neurological Sciences 1990 98 235-243. (doi:10.1016/0022-510X(90)90264-N)
38. Sewdarsen M, Vythilingum S, Jialal I, Desai RK & Becker P. Abnormalities in sex hormones are a risk factor for premature manifestation of coronary artery disease in South African Indian men. Atherosclerosis 1990 83 111-117. (doi:10.1016/0021-9150(90)90156-D)
39. Dash RJ, Sethi BK, Nalini K & Singh S. Circulating testosterone in pure motor stroke. Functional Neurology 1991 6 29-34.
40. Hauner H, Stangl K, Burger K, Busch U, Blömer H & Pfeiffer EF. Sex hormone concentrations in men with angiographically assessed coronary artery disease - relationship to obesity and body fat distribution. Klinische Wochenschrift 1991 69 664-668. (doi:10.1007/BF01649428)
41. Rice T, Sprecher DL, Borecki IB, Mitchell LE, Laskarzewski PM & Rao DC. Cincinnati myocardial infarction and hormone family study: family resemblance for testosterone in random and MI families. American Journal of Medical Genetics 1993 47 542-549. (doi:10.1002/ajmg.1320470421)
42. Hautanen A, Mänttäri M, Manninen V, Tenkanen L, Huttunen JK, Frick MH & Adlercreutz H. Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study. Atherosclerosis 1994 105 191-200. (doi:10.1016/0021- 9150(94)90049-3)
43. Marques-Vidal P, Sie P, Cambou JP, Chap H & Perret B. Relationships of plasminogen activator inhibitor activity and lipoprotein(a) with insulin, testosterone, 17 beta-estradiol, and testosterone binding globulin in myocardial infarction patients and healthy controls. Journal of Clinical Endocrinology and Metabolism 1995 80 1794-1798. (doi:10.1210/jc.80.6.1794)
44. Jeppesen LL, Jørgensen HS, Nakayama H, Raaschou HO, Olsen TS & Winther K. Decreased serum testosterone in men with acute ischemic stroke. Arteriosclerosis, Thrombosis, and Vascular Biology 1996 16 749-754. (doi:10.1161/01.ATV.16.6.749)
45. Phillips GB, Pinkernell BH & Jing TY. The association of hyperestrogenemia with coronary thrombosis in men. Arteriosclerosis, Thrombosis, and Vascular Biology 1996 16 1383-1387. (doi:10.1161/01.ATV.16.11.1383)
46. Price JF, Lee AJ & Fowkes FG. Steroid sex hormones and peripheral arterial disease in the Edinburgh Artery Study. Steroids 1997 62 789-794. (doi:10.1016/S0039-128X(97)00103-7)
47. Tripathi Y & Hegde BM. Serum estradiol and testosterone levels following acute myocardial infarction in men. Indian Journal of Physiology and Pharmacology 1998 42 291-294. (Pubitemid 28179872)
48. Zhao SP & Li XP. The association of low plasma testosterone level with coronary artery disease in Chinese men. International Journal of Cardiology 1998 63 161-164. (doi:10.1016/S0167- 5273(97)00295-7)
49. Kabakci G, Yildirir A, Can I, Unsal I & Erbas B. Relationship between endogenous sex hormone levels, lipoproteins and coronary atherosclerosis in men undergoing coronary angiography. Cardiology 1999 92 221-225. (doi:10.1159/ 000006977)
50. Chearskul S, Charoenlarp K, Thongtang V & NitiyanantW. Study of plasma hormones and lipids in healthy elderly Thais compared to patients with chronic diseases: diabetes mellitus, essential hypertension and coronary heart disease. Journal of the Medical Association of Thailand 2000 83 266-277.
51. English KM, Mandour O, Steeds RP, Diver MJ, Jones TH & Channer KS. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. European Heart Journal 2000 21 890-894. (doi:10.1053/euhj. 1999.1873)
52. Dobrzycki S, Serwatka W, Nadlewski S, Korecki J, Jackowski R, Paruk J, Ladny JR & Hirnle T. An assessment of correlations between endogenous sex hormone levels and the extensiveness of coronary heart disease and the ejection fraction of the left ventricle in males. Journal of Medical Investigation 2003 50 162-169. (Pubitemid 38019763)
53. Siemińska L, Wojciechowska C, Swietochowska E, Marek B, Kos- Kudła B, Kajdaniuk D & Nowalany-Kozielska E. Serum free testosterone in men with coronary artery atherosclerosis. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 2003 9 CR162-CR166. (Pubitemid 36713437)
54. Dunajska K, Milewicz A, Jedrzejuk D, Szymczak J, Kuliczkowski W, Salomon P, Bialy D, Poczatek K & Nowicki P. Plasma adiponectin concentration in relation to severity of coronary atherosclerosis and cardiovascular risk factors in middle-aged men. Endocrine 2004 25 215-221. (doi:10.1385/ ENDO:25:3:215)
55. Dunajska K, Milewicz A, Szymczak J, Jêdrzejuk D, Kuliczkowski W, Salomon P & Nowicki P. Evaluation of sex hormone levels and some metabolic factors in men with coronary atherosclerosis. Aging Male 2004 7 197-204. (doi:10.1080/ 13685530400004181)
56. Fischer F, Schulte H, Mohan S, Tataru MC, Köhler E, Assmann G & von Eckardstein A. Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease. Clinical Endocrinology 2004 61 595-602. (doi:10.1111/j.1365-2265.2004. 02136.x)
57. Kajinami K, Takeda K, Takekoshi N, Matsui S, Tsugawa H, Kanemitsu S, Okubo S, Kitayama M & Fukuda A. Imbalance of sex hormone levels in men with coronary artery disease. Coronary Artery Disease 2004 15 199-203. (Pubitemid 38879570)
58. Mikulec KH, Holloway L, Krasnow RE, Javitz H, Swan GE, Reed T, Marcus R & Carmelli D. Relationship of endogenous sex hormones to coronary heart disease: a twin study. Journal of Clinical Endocrinology and Metabolism 2004 89 1240-1245. (doi:10.1210/jc.2003-031333)
59. Demirbag R, Yilmaz R, Ulucay A & Unlu D. The inverse relationship between thoracic aortic intima media thickness and testosterone level. Endocrine Research 2005 31 335-344. (doi:10.1080/07435800500449494)
60. Davoodi G, Amirezadegan A, Borumand MA, Dehkori MR, Kazemisaeid A & Yaminisharif A. The relationship between level of androgenic hormones and coronary artery disease in men. Cardiovascular Journal of Africa 2007 18 362-366. (Pubitemid 351300619)
61. He H, Yang F, Liu X, Zeng X, Hu Q, Zhu Q & Tu B. Sex hormone ratio changes in men and postmenopausal women with coronary artery disease. Menopause 2007 14 385-390. (doi:10.1097/01. gme.0000235369.24479.dd)
62. Mohamad MJ, Mohammad MA, Karayyem M, Hairi A & Hader AA. Serum levels of sex hormones in men with acute myocardial infarction. Neuro Endocrinology Letters 2007 28 182-186. (Pubitemid 46739070)
63. Turhan S, Tulunay C, Güleç S, Ozdöl C, Kilickap M, Altin T, Gerede M & Erol C. The association between androgen levels and premature coronary artery disease in men. Coronary Artery Disease 2007 18 159-162. (doi:10.1097/MCA. 0b013e328012a928)
64. Debing E, Peeters E, Duquet W, Poppe K, Velkeniers B & Van Den Brande P. Men with atherosclerotic stenosis of the carotid artery have lower testosterone levels compared with controls. International Angiology: a Journal of the International Union of Angiology 2008 27 135-141.
65. Fu L, Gao QP & Shen JX. Relationship between testosterone and indexes indicating endothelial function in male coronary heart disease patients. Asian Journal of Andrology 2008 10 214-218. (doi:10.1111/j.1745-7262.2008.00335.x)
66. Page ST, Mohr BA, Link CL, O'Donnell AB, Bremner WJ & McKinlay JB. Higher testosterone levels are associated with increased high-density lipoprotein cholesterol in men with cardiovascular disease: results from the Massachusetts Male Aging Study. Asian Journal of Andrology 2008 10 193-200. (doi:10.1111/j.1745-7262.2008.00332.x)
67. Fallah N, Mohammad K, Nourijelyani K, Eshraghian MR, Seyyedsalehi SA, Raiessi M, Rahmani M, Goodarzi HR, Darvish S, Zeraati H, Davoodi G & Sadeghian S. Nonlinear association between serum testosterone levels and coronary artery disease in Iranian men. European Journal of Epidemiology 2009 24 297-306. (doi:10.1007/s10654-009-9336-9)
68. Cao J, Zou H, Zhu BP,Wang H, Li J, Ding Y & Li XY. Sex hormones and androgen receptor: risk factors of coronary heart disease in elderly men. Chinese Medical Sciences Journal 2010 25 44-49. (doi:10.1016/S1001-9294(10) 60019-3)
69. Cauley JA, Gutai JP, Kuller LH & Dai WS. Usefulness of sex steroid hormone levels in predicting coronary artery disease in men. American Journal of Cardiology 1987 60 771-777. (doi:10.1016/ 0002-9149(87)91021-6)
70. Contoreggi CS, Blackman MR, Andres R, Muller DC, Lakatta EG, Fleg JL & Harman SM. Plasma levels of estradiol, testosterone, and DHEAS do not predict risk of coronary artery disease in men. Journal of Andrology 1990 11 460-470. (Pubitemid 20359946)
71. Yarnell JW, Beswick AD, Sweetnam PM & Riad-Fahmy D. Endogenous sex hormones and ischemic heart disease in men. The Caerphilly Prospective Study. Arteriosclerosis and Thrombosis: a Journal of Vascular Biology/American Heart Association 1993 13 517-520. (doi:10.1161/01.ATV.13.4.517)
72. Khaw KT, DowsettM, Folkerd E, Bingham S,WarehamN, Luben R, WelchA& DayN. Endogenous testosterone andmortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 2007 116 2694-2701. (doi:10.1161/CIRCULATIONAHA.107.719005)
73. Lehtonen A, Huupponen R, Tuomilehto J, Lavonius S, Arve S, Isoaho H, Huhtaniemi I & Tilvis R. Serum testosterone but not leptin predicts mortality in elderly men. Age and Ageing 2008 37 461-464. (doi:10.1093/ageing/ afn048)
74. Yeap BB, Hyde Z, Almeida OP, Norman PE, Chubb SA, Jamrozik K, Flicker L & Hankey GJ. Lower testosterone levels predict incident stroke and transient ischemic attack in older men. Journal of Clinical Endocrinology and Metabolism 2009 94 2353-2359. (doi:10.1210/jc.2008-2416)
75. Corona G, Monami M, Boddi V, Cameron-Smith M, Fisher AD, de Vita G, Melani C, Balzi D, Sforza A, Forti G, Mannucci E & Maggi M. Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction. Journal of Sexual Medicine 2010 7 1557-1564. (doi:10.1111/j. 1743-6109.2009.01690.x)
76. Rosano GM, Leonardo F, Pagnotta P, Pelliccia F, Panina G, Cerquetani E, della Monica PL, Bonfigli B, Volpe M & Chierchia SL. Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation 1999 99 1666-1670. (Pubitemid 29162477)
77. Webb CM, Adamson DL, de Zeigler D & Collins P. Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. American Journal of Cardiology 1999 83 437-439. (doi:10.1016/S0002-9149(98) 00880-7)
78. English KM, Steeds RP, Jones TH, Diver MJ & Channer KS. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation 2000 102 1906-1911.
79. Thompson PD, Ahlberg AW, Moyna NM, Duncan B, Ferraro- Borgida M, White CM, McGill CC & Heller GV. Effect of intravenous testosterone on myocardial ischemia in men with coronary artery disease. American Heart Journal 2002 143 249-256. (doi:10.1067/mhj.2002.120144)
80. Malkin CJ, Pugh PJ, Morris PD, Kerry KE, Jones RD, Jones TH & Channer KS. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart 2004 90 871-876. (doi:10.1136/hrt.2003. 021121)
81. Mathur A, Malkin C, Saeed B, Muthusamy R, Jones TH & Channer K. Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men. European Journal of Endocrinology 2009 161 443-449. (doi:10.1530/EJE- 09-0092)
82. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ & McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 1996 17 1-12. (doi:10.1016/0197-2456(95) 00134-4)
83. Rosano GM, Sheiban I, Massaro R, Pagnotta P, Marazzi G, Vitale C, Mercuro G, Volterrani M, Aversa A & Fini M. Low testosterone levels are associated with coronary artery disease in male patients with angina. International Journal of Impotence Research 2007 19 176-182. (doi:10.1038/sj.ijir.3901504)
84. Corona G, Mannucci E, Forti G & Maggi M. Hypogonadism ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases. International Journal of Andrology 2009 32 587-598. (doi:10.1111/j.1365-2605. 2008.00951.x)
85. Corona G, Rastrelli G, Morelli A, Vignozzi L, Mannucci E & Maggi M. Hypogonadism and metabolic syndrome. Journal of Endocrinological Investigation 2011 34 557-567.
86. Corona G, Mannucci E, Fisher AD, Lotti F, Petrone L, Balercia G, Bandini E, Forti G & Maggi M. Low levels of androgens in men with erectile dysfunction and obesity. Journal of Sexual Medicine 2008 5 2454-2463.
87. Ding EL, Song Y, Malik VS & Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. Journal of the American Medical Association 2006 295 1288-1299. (doi:10.1001/jama.295.11.1288)
88. Corona G, Monami M, Rastrelli G, Aversa A, Sforza A, Lenzi A, Forti G, Mannucci E & Maggi M. Type 2 diabetes mellitus and testosterone: a meta-analysis study. International Journal of Andrology, 2011 In press. (doi:10.1111/j.1365-2605.2010. 01117.x)
89. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS & Montori VM. Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2010 95 2536-2559. (doi:10.1210/jc.2009-2354)
90. Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva F, Forti G, Giwercman A, Huhtaniemi IT, Kula K, Punab M, Boonen S, Vanderschueren D & European Male Aging Study Group . Hypothalamic-pituitary- testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. Journal of Clinical Endocrinology and Metabolism 2008 93 2737-2745. (doi:10.1210/jc.2007-1972)
91. Kienitz T & Quinkler M. Testosterone and blood pressure regulation. Kidney & Blood Pressure Research 2008 31 71-79. (doi:10.1159/000119417)
92. Hughes GS, Mathur RS & Margolius HS. Sex steroid hormones are altered in essential hypertension. Journal of Hypertension 1989 7 181-187. (doi:10.1097/00004872-198903000- 00003)
93. Svartberg J, von Mühlen D, Schirmer H, Barrett-Connor E, Sundfjord J & Jorde R. Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromsø Study. European Journal of Endocrinology 2004 150 65-71. (doi:10.1530/eje.0.1500065)
94. Corona G, Mannucci E, Lotti F, Fisher AD, Bandini E, Balercia G, Forti G & Maggi M. Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED. Journal of Sexual Medicine 2009 6 285-293. (doi:10.1111/j.1743-6109.2008.01059.x)
95. Corona G, Rastrelli G, Monami M, Melani C, Balzi D, Sforza A, Forti G, Mannucci E & Maggi M. Body mass index regulates hypogonadism- associatedCVrisk: results from a cohort of subjects with erectile dysfunction. Journal of Sexual Medicine 2011 8 2098-2105. (doi:10.1111/j.1743-6109.2011. 02292.x)
96. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC & Stewart PM. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 2001 357 425-431. (doi:10.1016/S0140-6736(00)04006-X)
97. Bojesen A, Juul S, Birkebaek N & Gravholt CH. Increased mortality in Klinefelter syndrome. Journal of Clinical Endocrinology and Metabolism 2004 89 3830-3834. (doi:10.1210/jc.2004-0777)
98. Hamilton JB & Mestler GE. Mortality and survival: comparison of eunuchs with intact men and women in a mentally retarded population. Journal of Gerontology 1969 24 395-411.
99. Shores MM, Matsumoto AM, Sloan KL & Kivlahan DR. Low serum testosterone and mortality in male veterans. Archives of Internal Medicine 2006 166 1660-1665. (doi:10.1001/archinte.166.15.1660)
100. Keating NL, O'Malley AJ & Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. Journal of Clinical Oncology 2006 24 4448-4456. (doi:10.1200/JCO.2006.06.2497)
101. Saigal CS, Gore JL, Krupski TL, Hanley J, Schonlau M, Litwin MS & Urologic Diseases in America Project . Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer 2007 110 1493-1500. (doi:10.1002/cncr.22933)
102. Tsai HK, D'Amico AV, Sadetsky N, Chen MH & Carroll PR. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. Journal of National Cancer Institute 2007 99 1516-1524. (doi:10.1093/jnci/djm168)
103. D'Amico AV, Denham JW, Crook J, Chen MH, Goldhaber SZ, Lamb DS, Joseph D, Tai KH, Malone S, Ludgate C, Steigler A & Kantoff PW. Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. Journal of Clinical Oncology 2007 25 2420-2425. (doi:10.1200/JCO.2006.09.3369)
104. D'Amico AV, Chen MH, Renshaw AA, Loffredo M & Kantoff PW. Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer. Cancer 2008 113 3290-3297. (doi:10.1002/cncr.23970)
105. Smith GD, Ben-Shlomo Y, Beswick A, Yarnell J, Lightman S & Elwood P. Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly Study. Circulation 2005 112 332-340. (doi:10.1161/CIRCULATIONAHA. 104.489088)
106. Arnlöv J, Pencina MJ, Amin S, Nam BH, Benjamin EJ, Murabito JM, Wang TJ, Knapp PE, D'Agostino RB Sr, Bhasin S & Vasan RS. Endogenous sex hormones and cardiovascular disease incidence in men. Annals of Internal Medicine 2006 145 176-184. (Pubitemid 46780562)
107. Abbott RD, Launer LJ, Rodriguez BL, Ross GW, Wilson PW, Masaki KH, Strozyk D, Curb JD, Yano K, Popper JS & Petrovitch H. Serum estradiol and risk of stroke in elderly men. Neurology 2007 68 563-568. (doi:10.1212/01.wnl. 0000254473.88647.ca)
108. Vikan T, Schirmer H, Njølstad I & Svartberg J. Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromsø Study. European Journal of Endocrinology 2009 161 435-442. (doi:10.1530/EJE-09-0284)
109. Caminiti G, Volterrani M, Iellamo F, Marazzi G, Massaro R, Miceli M, Mammi C, Piepoli M, Fini M & Rosano GM. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. Journal of the American College of Cardiology 2009 54 919-927. (doi:10.1016/j.jacc.2009.04.078)
110. Jankowska EA, Filippatos G, Ponikowska B, Borodulin-Nadzieja L, Anker SD, Banasiak W, Poole-Wilson PA & Ponikowski P. Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure. Journal of Cardiac Failure 2009 15 442-450. (doi:10.1016/j.cardfail.2008.12.011)
111. Isidori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V, Isidori A, Lenzi A & Fabbri A. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clinical Endocrinology 2005 63 280-293. (doi:10.1111/j.1365-2265.2005.02339.x)
112. Whitsel EA, Boyko EJ, Matsumoto AM, Anawalt BD & Siscovick DS. Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis. American Journal of Medicine 2001 111 261-269. (doi:10.1016/S0002-9343(01)00833-6)
113. Corona G, Monami M, Rastrelli G, Aversa A, Tishova Y, Saad F, Lenzi A, Forti G, Mannucci E & Maggi M. Testosterone and metabolic syndrome: a meta-analysis study. Journal of Sexual Medicine 2011 8 272-283. (doi:10.1111/j.1743-6109.2010.01991.x)
114. Haddad RM, Kennedy CC, Caples SM, Tracz MJ, Boloña ER, Sideras K, Uraga MV, Erwin PJ & Montori VM. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clinic Proceedings 2007 82 29-39. (doi:10.4065/82.1.29)
115. Fernández-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F, Mullan RJ, Agrwal N, Elamin MB, Gallegos- Orozco JF, Wang AT, Erwin PJ, Bhasin S & Montori VM. Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 2010 95 2560-2575. (doi:10.1210/jc.2009-2575)
116. Hyde Z, Flicker L, Almeida OP, Hankey GJ, McCaul KA, Chubb SA & Yeap BB. Low free testosterone predicts frailty in older men: the health in men study. Journal of Clinical Endocrinology and Metabolism 2010 95 3165-3172. (doi:10.1210/jc.2009-2754)
117. Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM, Eder R, Tennstedt S, Ulloor J, Zhang A, Choong K, Lakshman KM, Mazer NA, Miciek R, Krasnoff J, Elmi A, Knapp PE, Brooks B, Appleman E, Aggarwal S, Bhasin G, Hede- Brierley L, Bhatia A, Collins L, LeBrasseur N, Fiore LD & Bhasin S. Adverse events associated with testosterone administration. New England Journal of Medicine 2010 36 3109-3122.
118. Srinivas-Shankar U, Roberts SA, Connolly MJ, O'Connell MD, Adams JE, Oldham JA & Wu FC. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, doubleblind, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 2010 95 639-650. (doi:10.1210/jc.2009- 1251)
119. Kjaergaard AD, Ellervik C, Tybjaerg-Hansen A, Axelsson CK, Grønholdt ML, Grande P, Jensen GB & Nordestgaard BG. Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis. Circulation 2007 115 861-871. (doi:10.1161/CIRCULATIONAHA.106.615567)
120. Shearman AM, Cupples LA, Demissie S, Peter I, Schmid CH, Karas RH, Mendelsohn ME, Housman DE & Levy D. Association between estrogen receptor alpha gene variation and cardiovascular disease. Journal of the American Medical Association 2003 290 2263-2270. (doi:10.1001/jama.290.17.2263)
121. Kunnas TA, Laippala P, Penttilä A, Lehtimäki T & Karhunen PJ. Association of polymorphism of human alpha oestrogen receptor gene with coronary artery disease in men: a necropsy study. British Medical Journal 2000 321 273-274. (doi:10.1136/bmj. 321.7256.273)
122. Shearman AM, Cooper JA, Kotwinski PJ, Humphries SE, Mendelsohn ME, Housman DE & Miller GJ. Estrogen receptor alpha gene variation and the risk of stroke. Stroke 2005 36 2281-2282. (doi:10.1161/01.STR.0000181088.76518.ec)
123. Jankowska EA, Rozentryt P, Ponikowska B, Hartmann O, Kustrzycka- Kratochwil D, Reczuch K, Nowak J, Borodulin-Nadzieja L, Polonski L,BanasiakW,Poole-WilsonPA,AnkerSD&PonikowskiP. Circulating estradiol and mortality in men with systolic chronic heart failure. Journal of the American Medical Association 2009 301 1892-1901. (doi:10.1001/jama.2009.639)
124. Angstwurm MW, Gaertner R & Schopohl J. Outcome in elderly patients with severe infection is influenced by sex hormones but not gender. Critical Care Medicine 2005 33 2786-2793. (doi:10. 1097/01.CCM.0000190242.24410.17)
125. Giagulli VA, Kaufman JM & Vermeulen A. Pathogenesis of the decreased androgen levels in obese men. Journal of Clinical Endocrinology and Metabolism 1994 79 997-1000. (doi:10. 1210/jc.79.4.997)
126. Vermeulen A, Kaufman JM, Deslypere JP & Thomas G. Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men. Journal of Clinical Endocrinology and Metabolism 1993 76 1140-1146. (doi:10.1210/jc.76.5.1140)
127. Yadid G, Sudai E, Maayan R, Gispan I & Weizman A. The role of dehydroepiandrosterone (DHEA) in drug-seeking behavior. Neuroscience and Biobehavioral Reviews 2010 35 303-314. (doi:10.1016/j.neubiorev.2010.03.003)
128. Yen SS. Dehydroepiandrosterone sulfate and longevity: new clues for an old friend. PNAS 2001 98 8167-8169. (doi:10.1073/ pnas.161278698)
129. Buvat J. Androgen therapy with dehydroepiandrosterone. World Journal of Urology 2003 21 346-355. (doi:10.1007/s00345- 003-0367-7)
130. Barrett-Connor E, Khaw KT & Yen SS. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. New England Journal of Medicine 1986 315 1519-1524. (doi:10.1056/ NEJM198612113152405)
131. Legrain S, Berr C, Frenoy N, Gourlet V, Debuire B & Baulieu EE. Dehydroepiandrosterone sulfate in a long-term care aged population. Gerontology 1995 41 343-351. (doi:10.1159/000213706)
132. Tilvis RS, Kähönen M & Härkönen M. Dehydroepiandrosterone sulfate, diseases and mortality in a general aged population. Aging 1999 11 30-34. (Pubitemid 29174098)
133. Feldman HA, Johannes CB, Araujo AB, Mohr BA, Longcope C & McKinlay JB. Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study. American Journal of Epidemiology 2001 153 79-89. (doi:10.1093/aje/153.1.79)
134. Kähönen MH, Tilvis RS, Jolkkonen J, Pitkälä K & Härkönen M. Predictors and clinical significance of declining plasma dehydroepiandrosterone sulfate in old age. Aging 2000 12 308-314.
135. Sanders JL, Boudreau RM, Cappola AR, Arnold AM, Robbins J, Cushman M & Newman AB. Cardiovascular disease is associated with greater incident dehydroepiandrosterone sulfate decline in the oldest old: the cardiovascular health study all stars study. Journal of the American Geriatrics Society 2010 58 421-426. (doi:10.1111/j.1532-5415.2010.02724.x)
136. Aversa A, Bruzziches R, Francomano D, Rosano G, Isidori AM, Lenzi A & Spera G. Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebocontrolled study. Journal of Sexual Medicine 2010 7 3495-3503. (doi:10.1111/j.1743-6109. 2010.01931.x)